The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-Adamantan-1-ylmethyl-5-[3-((R)-2-hydroxy-1-methyl-ethylamino)-propyl]-2-methyl-benzamide ID: ALA4088943
PubChem CID: 137642766
Max Phase: Preclinical
Molecular Formula: C25H38N2O2
Molecular Weight: 398.59
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Cc1ccc(CCCN[C@H](C)CO)cc1C(=O)NCC12CC3CC(CC(C3)C1)C2
Standard InChI: InChI=1S/C25H38N2O2/c1-17-5-6-19(4-3-7-26-18(2)15-28)11-23(17)24(29)27-16-25-12-20-8-21(13-25)10-22(9-20)14-25/h5-6,11,18,20-22,26,28H,3-4,7-10,12-16H2,1-2H3,(H,27,29)/t18-,20?,21?,22?,25?/m1/s1
Standard InChI Key: VKEJEPXFDMHETM-NCJOGADSSA-N
Molfile:
RDKit 2D
29 32 0 0 0 0 0 0 0 0999 V2000
36.7026 -9.3812 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.5505 -8.5767 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.7736 -8.3044 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.1533 -8.8452 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
37.1666 -8.0359 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
37.9434 -8.3038 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.5638 -7.7672 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.3406 -8.0352 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.9610 -7.4987 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.8041 -6.6887 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.4320 -6.1520 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.2093 -6.4253 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.3631 -7.2356 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.7426 -7.7721 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.8332 -5.8929 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.2826 -5.3461 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.9034 -4.8107 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
39.5081 -5.0714 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
39.3544 -4.2656 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.5799 -3.9952 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.9927 -4.7352 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.1774 -4.4112 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.3048 -4.6559 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.9974 -3.9168 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.7680 -4.1936 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.9974 -3.0478 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.7772 -2.7725 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.1774 -3.4874 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.5799 -3.1039 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 6
2 3 1 0
3 4 1 0
2 5 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 1 0
9 10 2 0
11 10 1 0
12 11 2 0
13 12 1 0
14 13 2 0
9 14 1 0
12 15 1 0
11 16 1 0
16 17 2 0
16 18 1 0
18 19 1 0
19 20 1 0
20 21 1 0
22 21 1 0
23 22 1 0
24 23 1 0
25 24 1 0
20 25 1 0
24 26 1 0
27 26 1 0
28 27 1 0
22 28 1 0
27 29 1 0
20 29 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 398.59Molecular Weight (Monoisotopic): 398.2933AlogP: 3.84#Rotatable Bonds: 9Polar Surface Area: 61.36Molecular Species: BASEHBA: 3HBD: 3#RO5 Violations: ┄HBA (Lipinski): 4HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 9.81CX LogP: 4.00CX LogD: 1.65Aromatic Rings: 1Heavy Atoms: 29QED Weighted: 0.55Np Likeness Score: -0.64
References 1. Warner DJ, Chen H, Cantin LD, Kenna JG, Stahl S, Walker CL, Noeske T.. (2012) Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification., 40 (12): [PMID:22961681 ] [10.1124/dmd.112.047068 ]